# Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

> **NCT05720624** · PHASE1 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Malignant Central Nervous System Neoplasm

## Interventions

- **DRUG:** Anhydrous Enol-oxaloacetate
- **OTHER:** Best Practice
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Magnetic Resonance Spectroscopic Imaging
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT05720624
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-10-20
- **Primary completion:** 2025-10-20
- **Final completion:** 2025-10-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding issues
- **Last updated:** 2025-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05720624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05720624, "Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05720624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*